. HSV-1 infection efficacy and downstream signaling pathway in keratinocytes and Langerhans cells. (a) HSV-1 copies of HSV-1-treated primary keratinocytes were analyzed by RT-PCR and show a significant increase compared to untreated keratinocytes after 24 hours. Results are expressed as mean ± SEM from three independent experiments with different donors. **P<0. 01, ud (undetectable). (b)Representative western blot indicates expression of typical HSV-1specific glyoproteins in HSV-1-infected but not untreated (UT) keratinocytes when analyzed at 24 hours after infection. Ponceau S staining is included as loading control.
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Figure S1
HSV -1 copies (c, d) Immunofluorescence staining was performed on untreated and HSV-1-treated primary keratinocytes and freshly isolated and sorted CD207+ Langerhans cells. Translocation of ICP8, p65 and IRF3 from the cytoplasm into the nucleus is observed at 24 hours in HSV-1-treated but not untreated keratinocytes and Langerhans cells when analyzed with confocal microscopy. White arrows denote representative cells in insert with single colour labelling. Nuclear counterstain was performed with Hoechst. Shown is one representative staining out of three independent experiments. Scale bar = 10 µm. H, Hoechst
Supplementary Figure 2 . Pretelivir inhibits viral replication in in vitro cell culture assays and shows potency to reverse the infection in an ex vivo skin model. (a) Treatment of primary keratinocytes with pritelivir (dissolved in 0.3% to 0.001% DMSO) shows no significant toxicity at any indicated concentration compared to control (media), when analyzed with EZ4U while the positive control (cont; 3% DMSO) is highly significant. Absorbance shown is the ratio of pritelivir and DMSO measured at 492 nm with a reference wavelength of 620 nm after 48 h of treatment.
Results are expressed as mean ± SEM from three independent experiments with different donors. (b) HSV-1 copies in primary keratinocytes at 24 hours was measured after indicated treatments. Results expressed as mean ± SEM are from three independent experiments with different donors. + (treated), − (untreated). **P<0.01, ***P<0.001. (c) Representative western blot reveals HSV-1 specific glyoprotein expression after indicated treatment in primary keratinocytes at 24 hours. Ponceau S staining is included as loading control. 
